David Moatazedi is the President and Chief Executive Officer at EVOLUS INC, a performance beauty company focused on delivering innovative and differentiated aesthetic products. With an extensive background in the healthcare and pharmaceutical industries, Moatazedi has demonstrated a strong track record of leadership and strategic vision throughout his career. Prior to joining EVOLUS INC, he held various executive positions at Allergan, a global pharmaceutical company, where he played a key role in driving growth and expanding the company's portfolio of products. As President and CEO of EVOLUS INC, Moatazedi is responsible for overseeing the company's overall strategy, operations, and growth initiatives. Under his leadership, EVOLUS INC has successfully launched Jeuveau®, the first and only neurotoxin dedicated exclusively to aesthetics, which has quickly gained popularity among patients and healthcare professionals alike. Moatazedi's strategic vision and commitment to innovation have been instrumental in positioning EVOLUS INC as a leader in the aesthetic industry. Throughout his tenure at EVOLUS INC, David Moatazedi has been recognized for his ability to build strong teams, foster a culture of collaboration, and drive results. His passion for delivering high-quality, patient-centric solutions has been a driving force behind the company's success. With his extensive experience and leadership skills, Moatazedi continues to guide EVOLUS INC towards its mission of empowering individuals to look and feel their best.